Back To Schedule
Tuesday, March 5 • 4:00pm - 6:00pm
Global Health Challenges and Economic Implications FULL

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Limited Capacity seats available

The world has started facing a dramatic change in global health challenges. On top of the unmet needs to
combat communicable diseases especially in the developing world our societies become larger, older and unhealthier. We even export most of these life style diseases into the low and most prominently the medium income countries (LMIC). 2/3 of all new cancer cases in 2030 can be estimated to be diagnosed in LMIC, the highest increase in type 2 diabetes and glucose intolerance will be seen in LMICs. At the same time public health spending is increasing already and the need for an economic return for Pharma is becoming shorter. For big Innovations first stage funding is seen as too risky and seed funding instruments are unattractive for investors.

Healthcare systems have no proper solutions in place to cope with the upcoming health challenges and
countries have no strategy how to finance healthcare under these expected developments. This situation will result in a major threat for global economy. There is a need for new solutions for better prevention of diseases and more efficient cures. These solutions have to emerge from top level research requiring also new financing instruments to enable efficient translation of research into innovation.




avatar for Nessa Childers

Nessa Childers

Member of the European Parliament, European Parliament
Nessa Childers is an Irish Labour Party politician and Member of the European Parliament (MEP) for the Ireland East constituency.  Previously Nessa was a councillor for the Blackrock area of South Dublin 2004–2008.A member of the European Parliament's Committee on the Environment... Read More →

avatar for Peter Boyle

Peter Boyle

President of the International Prevention Research Institute, Lyon, France
Dr Boyle’s appointment as President of the International Prevention Research Institute, Lyon, France follows immediately on his tenure as Director of the International Agency for Research on Cancer (IARC/WHO) from 2004 to 2008 in Lyon, France. He previously had had a number of successive... Read More →
avatar for David Byrne

David Byrne

David Byrne was appointed EU Commissioner in 1999 and held the portfolio of Health and Consumer Affairs during the Prodi Commission, when he established the European Centre for Disease Control (ECDC) and the European Food Safety Authority (EFSA). Prior to that, he served as Attorney... Read More →
avatar for Geoffrey Hamilton-Fairley

Geoffrey Hamilton-Fairley

Executive Chairman, Oncimmune Ltd
Geoffrey Hamilton-Fairley’s entrepreneurial career started in 1982 by founding a number of companies in the media sector backed by The Abingdon Management Company Limited (Abingdon) - an institutional venture capital company. In 1988 he joined the board of Abingdon as CEO and subsequently... Read More →
avatar for Barbara James

Barbara James

Founder and CEO of Henshaw Capital Partners
Barbara is founder and CEO of the first independent pan-African private equity Fund of Funds - Henshaw Capital Partners. Barbara served on the Nigerian Federal Government Committee on Information Technology Incubation Centre Development in 2011/2012 and on the Nigerian Federal Ministry... Read More →
avatar for Martin Murphy

Martin Murphy

Chief Executive Officer of Syncona Partners LLP
Martin is the Chief Executive Officer of Syncona Partners LLP.  Previously, he was a Partner at MVM Life Science Partners LLP, a leading venture capital company focused on life science and healthcare investments. During his time at MVM, Martin was a member of the Management and Investment... Read More →
avatar for Andrea Ponti

Andrea Ponti

Managing Director, Co-Head of Global Healthcare
Andrea joined J.P. Morgan from Goldman Sachs where he was Partner Managing Director and Head of European Healthcare, Consumer and Retail based in London. In addition to founding the Goldman Sachs European Healthcare group in 1997, Andrea covered a variety of roles as Chief Operating... Read More →

Tuesday March 5, 2013 4:00pm - 6:00pm CET
European Parliament A3H1

Attendees (2)